Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Eur J Intern Med ; 25(8): 695-700, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25051902

ABSTRACT

International guidelines describe asthma control as the main outcome of asthma management. Prevention of symptoms, improved quality of life, and reduction of exacerbations are the main components, consequently decreasing health care costs. However, many of these objectives remain unmet in real life: several surveys show that a large proportion of asthmatic patients are not well controlled despite the efficacy of current available treatment. Several randomized controlled clinical trials indicate that combining inhaled corticosteroids and long-acting ß2-agonists, by means of a single inhaler, greatly improves the management of the disease. The results of 9 multicenter phase III clinical studies demonstrate that the fixed combination of fluticasone propionate/formoterol in a single inhaler is effective in terms of lung function and symptom control. These studies highlight the dose flexibility, safety and tolerability of this new inhaled combination. These characteristics meet the recommendations of international guidelines, and the preferences of respiratory physicians who identified these aspects as critical components of a successful asthma therapy. Combination of fluticasone propionate/formoterol in a single inhaler provides potent anti-inflammatory activity of fluticasone propionate and rapid onset of action of the ß2-agonist formoterol making this association a viable treatment option both in terms of effectiveness and compliance.


Subject(s)
Androstadienes/administration & dosage , Anti-Asthmatic Agents/administration & dosage , Asthma/drug therapy , Bronchodilator Agents/administration & dosage , Ethanolamines/administration & dosage , Asthma/physiopathology , Drug Combinations , Fluticasone , Forced Expiratory Volume , Formoterol Fumarate , Humans , Nebulizers and Vaporizers , Particle Size , Quality of Life , Treatment Outcome
2.
Monaldi Arch Chest Dis ; 65(2): 82-8, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16913578

ABSTRACT

BACKGROUND AND AIM: Community Acquired Pneumonia (CAP) remains a major cause of disease and death. We evaluated the levels of care, the outcome and the characteristics of hospitalised patients with CAP in a primary hospital in Italy. We also investigated the value of both the Pneumonia Severity Index (PSI) and the modified Appropriateness Evaluation Protocol (AEP) for recognising both the outcome and the unnecessary admissions and stay of hospitalised patients with CAP. METHODS: A retrospective review of all the charts of adult patients with CAP at Manerbio, Brescia, Italy between January 2001 and December 2002 was performed. RESULTS: We evaluated 148 patients; their mean age (+/-SD) was 70 (+/-17) years; 34% were female. Most patients (87%) had at least a concomitant co-morbid disease. The overall survival rate at 30 days was 88%. All but one death occurred in the high-risk group of patients according to the PSI. On the contrary, the death rate of patients with inappropriate hospital admission according to the AEP was high. Patients with high PSI score had a significantly longer hospital length of stay than the low-risk group. However, a substantial part of the hospital stay did not show any justification into the charts. CONCLUSIONS: The PSI, but not the AEP, upon hospital admission, was useful for evaluating the outcome of patients with CAP. The PSI score and the modified AEP can be useful for assessing the appropriateness of hospitalisation for patients with CAP. There is the need for a practical and validated tool to support physicians in their decision making regarding the early and safe discharge of hospitalised patients with CAP.


Subject(s)
Hospitalization , Pneumonia/epidemiology , Adolescent , Adult , Aged , Analysis of Variance , Community-Acquired Infections/epidemiology , Female , Humans , Italy/epidemiology , Length of Stay , Male , Middle Aged , Pneumonia/mortality , Prospective Studies , Retrospective Studies , Risk Factors , Surveys and Questionnaires , Survival Rate
3.
Respir Med ; 97(3): 221-7, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12645828

ABSTRACT

UNLABELLED: After strenuous physical exercise, many subjects show a significant bronchoconstriction and report dyspnea. Despite this clinical condition being a commonly encountered situation during daily life, which may be responsible for substantial disability there is little information on the relationship between the perception of dyspnea and exercise-induced bronchoconstriction (EIB) after a standardized exercise challenge. For these reasons, we evaluated 200 consecutive outpatients (median age 13 years, ranging from 5 to 56 years) referred to our laboratory to perform an exercise test out of suspicion of EIB. On exercise challenge, perception of dyspnea was rated on a modified bipolar Borg scale immediately before each FEV1 measurement. Sixty-nine (35%) subjects had a positive exercise challenge, defined as a decrease of at least 20% in FEV1 from baseline. Both the onset and the decay of dyspnea preceded those of bronchoconstriction. Overall, the rating of dyspnea in the laboratory was well related with the reports of exercise-related symptoms. Similarly, 36 of 77 (47%) asthmatics with a history of exertional symptoms and 24 of 65 patients (40%) without a history had a positive challenge. Asthmatics reporting exertional symptoms perceived a greater magnitude of dyspnea after exercise independently from the degree of bronchoconstriction. Overall, dyspnea was significantly but loosely correlated to the magnitude of decrease in FEV1, being also influenced by age, gender and BMI. CONCLUSIONS: We conclude that dyspnea recorded in the laboratory after exercise test is related to exertional symptoms reported during real life, but not completely related to EIB. The rating of dyspnea is a well-suited model to study naturally occurring exercise-induced dyspnea and a useful tool to enlarge the results of an exercise challenge.


Subject(s)
Bronchoconstriction/physiology , Dyspnea/etiology , Exercise/physiology , Adolescent , Adult , Child , Child, Preschool , Dyspnea/physiopathology , Female , Forced Expiratory Volume/physiology , Humans , Male , Middle Aged , Time Factors
4.
Monaldi Arch Chest Dis ; 57(5-6): 231-6, 2002.
Article in English | MEDLINE | ID: mdl-12814033

ABSTRACT

The GENEBU Project is an open, observational survey evaluating home nebulizer practices in Italy. It consecutively included patients who were referred to one of the 27 participating chest clinics from May to December 1999 and who had been using a home nebulizer in the previous six months. The information source was a self-administered questionnaire compiled by the enrolled subjects. We collected 1257 questionnaires. The nebulizer equipment was heterogeneous, with at least 92 different models. Jet nebulizers were 90% of the total; 53% of these had a glass reservoir. Almost 80% of the patients selected the nebulizer themselves without any medical advice. In addition, most patients (> 80%) did not receive information on both the interface system and the optimal fill volume of the nebulizer. Corticosteroid nebulisation was widespread (74%), for both occasional and regular daily use, for both acute and chronic diseases from upper to lower airways. Beta 2-agonist (55%), anticholinergic (37%), mucolytic (32%) drugs were also often nebulised. More than 90% of patients mixed some active drugs. We conclude that the nebulizer equipment for home aerosol therapy was very heterogeneous and, probably, not always utilised at its best in Italy. The mixing of drugs and the widespread use of corticosteroids were peculiarities of home nebulizer therapy in Italy.


Subject(s)
Nebulizers and Vaporizers , Adrenergic beta-Agonists/therapeutic use , Anti-Bacterial Agents/therapeutic use , Cross-Sectional Studies , Drug Utilization , Equipment Design , Expectorants/therapeutic use , Glucocorticoids/therapeutic use , Humans , Italy , Nebulizers and Vaporizers/statistics & numerical data , Surveys and Questionnaires
5.
Epidemiol Prev ; 25(4-5): 174-80, 2001.
Article in Italian | MEDLINE | ID: mdl-11789457

ABSTRACT

This retrospective, observational study was performed to evaluate the structure and the content of the nursing documentation in the Azienda ospedaliera Careggi, Firenze in 1998. To this aim we review 1964 nursing records including both notes by turns and care plans. One-thousand-one-hundred-and-twenty-five records came from surgical and 839 from medical wards. From the selected records, every day of the hospital stay, including both the admission and the discharge, were evaluated, so that the studied days were a total of 18,683. Only 32% of the nursing records had a global assessment of patient situation on admission. A medical diagnosis was observed in 84% of the cases, but a nursing diagnosis was absent in over 99.5% of the charts. During stay most notes were related to medical treatment and visits. Nursing notes were lacking in 32% of turns, while "nothing to report" was recorded in another 15.5% of cases. A nursing care plan was present in a minority of records. A final evaluation of planned nursing interventions was reported in approximately 5% of the charts. Nursing care plans were updated during stay in less than one tenth of cases. Discharges notes were absent in slightly more than 80% of the cases. This survey confirms the importance of continuing education and supervision in nursing documentations, if a reliable source of nursing information has to be developed. Future nursing records should include only essential information, avoiding any overlap with medical charts.


Subject(s)
Documentation/standards , Nursing/standards , Adolescent , Adult , Aged , Aged, 80 and over , Female , Health Services/standards , Hospitals, General , Humans , Italy , Male , Middle Aged , Retrospective Studies
6.
J Chemother ; 13(6): 628-34, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11806624

ABSTRACT

Lomefloxacin is a difluorinated quinolone with excellent activity against a wide range of pathogens including those responsible for acute exacerbations of chronic bronchitis (AECB). This open, cross-sectional, multicenter study has evaluated the efficacy and safety of a once-daily dosage of 400 mg lomefloxacin in patients with AECB chronically treated with theophylline. 137 patients (96 males, 41 females; mean age 66.1+/-11.2 yrs) were enrolled and 133 completed the study. 81% suffered from moderate AECB, 16% severe AECB. The clinical success rate was very high (95%), as well as the microbiological (93%). Side effects were scarce and were significant only in 3 patients, with 2 dropouts. All patients were using theophylline derivatives twice daily and continued without any variation in dosage during the lomefloxacin treatment. Theophylline plasma levels determined in 103 patients at baseline, during and at the end of the lomefloxacin treatment did not significantly change. We conclude that orally administered lomefloxacin at standard recommended dosage is well tolerated and effective in elderly patients with AECB. No dose adjustment is required even when it is co-administered with methylxanthines.


Subject(s)
Anti-Infective Agents/therapeutic use , Bronchitis/drug therapy , Fluoroquinolones , Pulmonary Disease, Chronic Obstructive/drug therapy , Quinolones/therapeutic use , Theophylline/therapeutic use , Acute Disease , Administration, Oral , Adult , Aged , Anti-Infective Agents/adverse effects , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Quinolones/adverse effects
7.
Eur Respir J ; 18(5): 758-63, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11757624

ABSTRACT

Due to the lack of information on this topic, the Educational Group of the Italian Association of Hospital Pneumologists performed an open, multicentre, observational survey to evaluate home nebulizer practices in Italy. From May-December 1999, all patients attending one of the 27 participating chest clinics throughout Italy and who were or had been using a home nebulizer in the previous 6 months were consecutively enrolled. All patients completed a self-administered questionnaire on their current practices of home nebulization. Of the 1,721 questionnaires delivered, 1,257 were returned with an overall response rate of 73%. Most patients (82.8%) reported using their nebulizer for bronchopulmonary symptoms and the remaining patients only used theirs for upper respiratory tract diseases. Subjects using their nebulizer for lower respiratory symptoms were older (p<0.001), predominantly female (p<0.001) and used their nebulizer more frequently (p<0.001). Forty per cent of patients >60 yrs old used their nebulizer regularly, at least once a day. More than 60% of respondents never received any information from healthcare workers on the correct usage of their nebulizer, and >75% received no information on nebulizer hygiene and care. Patients who received information on the use and maintenance of their nebulizer from caregivers more commonly attended to these practices (p<0.01). The present survey suggests that home nebulizer use and maintenance in Italy are heterogeneous, and there is the need to implement better nebulizer practice.


Subject(s)
Nebulizers and Vaporizers/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Asthma/therapy , Child , Child, Preschool , Cross-Sectional Studies , Disinfection , Female , Humans , Italy , Logistic Models , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/therapy
8.
Eur J Epidemiol ; 16(7): 607-11, 2000.
Article in English | MEDLINE | ID: mdl-11078116

ABSTRACT

In this study we evaluated the smoking habits, beliefs and attitudes of nurse and medical students at the University of Siena and Florence, Italy. Students who entered the 1st year of school in 1998 were asked to complete a self-administered anonymous questionnaire. Two hundred medical students completed the questionnaire; they had a mean age (+/-SD) of 19.8+/-1.7 years and 68% were females. A total of 205 nurse respondents answered to the questionnaire; they had a mean age of 21.8+/-4.1 years and females were 83% of the total. The overall response rate among students always remained higher than 85%. Thirty per cent of medical students were current smokers, and 5% former-smokers. A total of 43% of nurse students were current smokers and 11.5% former-smokers. Nurse students were more likely to smoke than medical students (p = 0.001). Among current smokers, the number of daily cigarettes smoked and the degree of nicotine addiction did not differ between groups. The prevalence of maternal smoking were higher among nurse students. In spite of students' beliefs the knowledge about smoking remained generic in both groups. Nurse students were less aware than medical students of their special responsibility towards people about tobacco smoking. Such a difference remained significant also after adjustment for smoking status (p < 0.01). Students overestimated the prevalence of current smokers among health caregivers of the local hospitals, and Italian people and adolescents. Targeted and continuous training about smoking prevention should be mandatory in Italian medical and nurse schools.


Subject(s)
Smoking/epidemiology , Students, Medical , Students, Nursing , Adolescent , Adult , Age Factors , Attitude of Health Personnel , Cross-Sectional Studies , Female , Humans , Italy/epidemiology , Male , Mothers , Smoking/adverse effects , Smoking Cessation , Smoking Prevention , Surveys and Questionnaires , Tobacco Use Disorder/epidemiology
9.
Monaldi Arch Chest Dis ; 54(3): 224-7, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10441974

ABSTRACT

Twenty male outpatients with severe-but-stable chronic obstructive pulmonary disease handicapped by exertional dyspnoea (aged 69.7 +/- 5.68 yrs; forced expiratory volume in one second (FEV1) 1.02 +/- 0.18 L or 34.6 +/- 6.5% of the predicted value; forced vital capacity (FVC) 2.51 +/- 0.34 L; arterial oxygen tension (Pa,O2) 9.11 +/- 0.32 kPa (68.5 +/- 2.4 mmHg); arterial carbon dioxide tension (Pa,CO2) 5.20 +/- 0.23 kPa (39.1 +/- 1.7 mmHg)) completed a randomized double-blind crossover study to evaluate the effects of a 4-week regular treatment with inhaled beclomethasone dipropionate via nebulizers at a dosage of 2 mg twice daily. After active and placebo treatment, no peak expiratory flow rate variation in FEV1, FVC, rescue use of beta 2-agonists, exercise tolerance and dyspnoea was observed. In conclusion, a regular short-term treatment with nebulized beclomethasone dipropionate does not give any improvement in lung function or exercise capacity in severe-but-stable chronic obstructive pulmonary disease patients handicapped by exertional dyspnoea.


Subject(s)
Beclomethasone/therapeutic use , Dyspnea/drug therapy , Glucocorticoids/therapeutic use , Lung Diseases, Obstructive/complications , Administration, Inhalation , Aerosols , Aged , Beclomethasone/administration & dosage , Cross-Over Studies , Double-Blind Method , Dyspnea/etiology , Dyspnea/physiopathology , Glucocorticoids/administration & dosage , Humans , Lung Diseases, Obstructive/physiopathology , Male , Physical Exertion , Respiratory Function Tests , Statistics, Nonparametric , Treatment Outcome
10.
Monaldi Arch Chest Dis ; 53(3): 274-6, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9785810

ABSTRACT

We report a paradoxical episode of near-fatal bronchoconstriction which occurred in an adult bronchiectatic subject, with chronic Pseudomonas aeruginosa airways colonization, immediately after his first inhalation of a gentamicin solution. This adverse reaction may be due to the gentamicin itself, the physical properties of the solution, or preservatives in the (commercially available) gentamicin solution.


Subject(s)
Anti-Bacterial Agents/adverse effects , Gentamicins/adverse effects , Respiratory Insufficiency/chemically induced , Administration, Inhalation , Aerosols , Aged , Anti-Bacterial Agents/administration & dosage , Bronchiectasis/complications , Gentamicins/administration & dosage , Humans , Male , Pseudomonas Infections/complications , Pseudomonas Infections/drug therapy , Respiratory Tract Infections/complications , Respiratory Tract Infections/drug therapy
11.
Monaldi Arch Chest Dis ; 52(4): 354-62, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9401366

ABSTRACT

Exertional dyspnoea is one of the most common and disabling symptoms in patients with stable chronic obstructive pulmonary disease (COPD). Because little can be done for its resolution, the idea of its symptomatic treatment is attractive. There is no gold standard for the pharmacological management of exertional dyspnoea in stable COPD. A reassessment of the available literature shows the current perspectives and limits.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Bronchodilator Agents/therapeutic use , Dyspnea/drug therapy , Lung Diseases, Obstructive/complications , Oxygen/therapeutic use , Psychotropic Drugs/therapeutic use , Clinical Trials as Topic , Cross-Over Studies , Double-Blind Method , Dyspnea/etiology , Dyspnea/physiopathology , Humans , Lung Diseases, Obstructive/physiopathology , Physical Exertion , Respiratory Function Tests , Treatment Outcome
12.
Eur J Epidemiol ; 13(8): 899-902, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9476819

ABSTRACT

This prospective cohort study has been performed to evaluate the changes in student nurses smoking habits and beliefs during their training. The source of information was an anonymous questionnaire about tobacco smoking, administered to students who entered the first year of School of Nursing in Florence in 1991-1992, 1992-1993 and 1993-1994. Five hundred and thirty-six (95%) of these student nurses completed the questionnaire. Five hundred and one (93%) of these 536 respondents completed the questionnaire again at the end of the third (final) year of training. Student nurses who smoked increased the average number of cigarettes smoked per day (p < 0.01) and the degree of dependence to nicotine (p < 0.01). Tobacco smoking remained widespread and the percentage of ex-smokers who started smoking again increased (p < 0.05). The knowledge about the health hazards due to tobacco smoking remained generic and the prevalence of current smokers among student nurses and health care workers was overestimated. We conclude that Nursing School does not succeed in reducing the smoking habits of students. Effective antitobacco strategies and smoking cessation services still need be organized in Italy.


Subject(s)
Attitude to Health , Health Knowledge, Attitudes, Practice , Smoking/epidemiology , Students, Nursing/statistics & numerical data , Adolescent , Adult , Asthma/epidemiology , Bronchitis/epidemiology , Cohort Studies , Coronary Artery Disease/epidemiology , Education, Nursing , Female , Health Behavior , Health Education , Health Promotion , Humans , Italy/epidemiology , Longitudinal Studies , Lung Neoplasms/epidemiology , Male , Middle Aged , Nicotine , Nurses/statistics & numerical data , Personnel, Hospital/statistics & numerical data , Prevalence , Prospective Studies , Recurrence , Smoking/adverse effects , Smoking Cessation/statistics & numerical data , Substance-Related Disorders/epidemiology , Surveys and Questionnaires
13.
Eur J Epidemiol ; 12(1): 1-3, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8817169

ABSTRACT

Six-hundred and sixty-two nurse students (aged 25.2 +/- 4.11 years; 153 were males) answered a self-administered, anonymous questionnaire about smoking habits and knowledges in a large urban Teaching School of Nursing. The overall response rate was 88%. Current smokers were 336 (51%), former smokers 80 (12%). Nurse students claimed to know the dangers of tobacco and nurse training seemed to modify the preferential source of information about tobacco smoking towards medical fonts; however, only a quarter of nurse students considered medical smoking cessation approaches as useful for quitting and advised patients with tobacco-related diseases against smoking.


Subject(s)
Health Knowledge, Attitudes, Practice , Smoking/psychology , Students, Nursing/psychology , Adult , Attitude of Health Personnel , Attitude to Health , Female , Health Education/methods , Humans , Male , Smoking Cessation/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...